Decreased severity of disease during the first global omicron variant covid-19 outbreak in a large hospital in tshwane, south africa
•the rapid rise and decline of admissions and decreased severity of COVID-19 disease•compares 466 patients in the Omicron wave to 3962 patients in previous waves•describes disease severity of all admitted patients at peak bed occupancy•a lower mortality rate from Omicron compared to previous waves T...
Saved in:
Published in | International journal of infectious diseases Vol. 116; pp. 38 - 42 |
---|---|
Main Authors | , , , , , , , , , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Canada
Elsevier Ltd
01.03.2022
The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases Elsevier |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | •the rapid rise and decline of admissions and decreased severity of COVID-19 disease•compares 466 patients in the Omicron wave to 3962 patients in previous waves•describes disease severity of all admitted patients at peak bed occupancy•a lower mortality rate from Omicron compared to previous waves
The coronavirus disease 2019 (COVID-19) first reported in Wuhan, China in December 2019 is a global pandemic that is threatening the health and wellbeing of people worldwide. To date there have been more than 274 million reported cases and 5.3 million deaths. The Omicron variant first documented in the City of Tshwane, Gauteng Province, South Africa on 9 November 2021 led to exponential increases in cases and a sharp rise in hospital admissions. The clinical profile of patients admitted at a large hospital in Tshwane is compared with previous waves.
466 hospital COVID-19 admissions since 14 November 2021 were compared to 3962 admissions since 4 May 2020, prior to the Omicron outbreak. Ninety-eight patient records at peak bed occupancy during the outbreak were reviewed for primary indication for admission, clinical severity, oxygen supplementation level, vaccination and prior COVID-19 infection. Provincial and city-wide daily cases and reported deaths, hospital admissions and excess deaths data were sourced from the National Institute for Communicable Diseases, the National Department of Health and the South African Medical Research Council.
For the Omicron and previous waves, deaths and ICU admissions were 4.5% vs 21.3% (p<0.00001), and 1% vs 4.3% (p<0.00001) respectively; length of stay was 4.0 days vs 8.8 days; and mean age was 39 years vs 49,8 years.
Admissions in the Omicron wave peaked and declined rapidly with peak bed occupancy at 51% of the highest previous peak during the Delta wave.
Sixty two (63%) patients in COVID-19 wards had incidental COVID-19 following a positive SARS-CoV-2 PCR test . Only one third (36) had COVID-19 pneumonia, of which 72% had mild to moderate disease. The remaining 28% required high care or ICU admission. Fewer than half (45%) of patients in COVID-19 wards required oxygen supplementation compared to 99.5% in the first wave. The death rate in the face of an exponential increase in cases during the Omicron wave at the city and provincial levels shows a decoupling of cases and deaths
compared to previous waves, corroborating the clinical findings of decreased severity of disease seen in patients admitted to the Steve Biko Academic Hospital.
There was decreased severity of COVID-19 disease in the Omicron-driven fourth wave in the City of Tshwane, its first global epicentre. |
---|---|
AbstractList | INTRODUCTION: The coronavirus disease 2019 (COVID-19) first reported in Wuhan, China in December 2019 is a global pandemic that is threatening the health and wellbeing of people worldwide. To date there have been more than 274 million reported cases and 5.3 million deaths. The Omicron variant first documented in the City of Tshwane, Gauteng Province, South Africa on 9 November 2021 led to exponential increases in cases and a sharp rise in hospital admissions. The clinical profile of patients admitted at a large hospital in Tshwane is compared with previous waves. METHODS: 466 hospital COVID-19 admissions since 14 November 2021 were compared to 3962 admissions since 4 May 2020, prior to the Omicron outbreak. Ninety-eight patient records at peak bed occupancy during the outbreak were reviewed for primary indication for admission, clinical severity, oxygen supplementation level, vaccination and prior COVID-19 infection. Provincial and city-wide daily cases and reported deaths, hospital admissions and excess deaths data were sourced from the National Institute for Communicable Diseases, the National Department of Health and the South African Medical Research Council. RESULTS: For the Omicron and previous waves, deaths and ICU admissions were 4.5% vs 21.3% (p<0.00001), and 1% vs 4.3% (p<0.00001) respectively; length of stay was 4.0 days vs 8.8 days; and mean age was 39 years vs 49,8 years.Admissions in the Omicron wave peaked and declined rapidly with peak bed occupancy at 51% of the highest previous peak during the Delta wave.Sixty two (63%) patients in COVID-19 wards had incidental COVID-19 following a positive SARS-CoV-2 PCR test . Only one third (36) had COVID-19 pneumonia, of which 72% had mild to moderate disease. The remaining 28% required high care or ICU admission. Fewer than half (45%) of patients in COVID-19 wards required oxygen supplementation compared to 99.5% in the first wave. The death rate in the face of an exponential increase in cases during the Omicron wave at the city and provincial levels shows a decoupling of cases and deathscompared to previous waves, corroborating the clinical findings of decreased severity of disease seen in patients admitted to the Steve Biko Academic Hospital. CONCLUSION: There was decreased severity of COVID-19 disease in the Omicron-driven fourth wave in the City of Tshwane, its first global epicentre. The coronavirus disease 2019 (COVID-19) first reported in Wuhan, China in December 2019 is a global pandemic that is threatening the health and wellbeing of people worldwide. To date there have been more than 274 million reported cases and 5.3 million deaths. The Omicron variant first documented in the City of Tshwane, Gauteng Province, South Africa on 9 November 2021 led to exponential increases in cases and a sharp rise in hospital admissions. The clinical profile of patients admitted at a large hospital in Tshwane is compared with previous waves. 466 hospital COVID-19 admissions since 14 November 2021 were compared to 3962 admissions since 4 May 2020, prior to the Omicron outbreak. Ninety-eight patient records at peak bed occupancy during the outbreak were reviewed for primary indication for admission, clinical severity, oxygen supplementation level, vaccination and prior COVID-19 infection. Provincial and city-wide daily cases and reported deaths, hospital admissions and excess deaths data were sourced from the National Institute for Communicable Diseases, the National Department of Health and the South African Medical Research Council. For the Omicron and previous waves, deaths and ICU admissions were 4.5% vs 21.3% (p<0.00001), and 1% vs 4.3% (p<0.00001) respectively; length of stay was 4.0 days vs 8.8 days; and mean age was 39 years vs 49,8 years. Admissions in the Omicron wave peaked and declined rapidly with peak bed occupancy at 51% of the highest previous peak during the Delta wave. Sixty two (63%) patients in COVID-19 wards had incidental COVID-19 following a positive SARS-CoV-2 PCR test . Only one third (36) had COVID-19 pneumonia, of which 72% had mild to moderate disease. The remaining 28% required high care or ICU admission. Fewer than half (45%) of patients in COVID-19 wards required oxygen supplementation compared to 99.5% in the first wave. The death rate in the face of an exponential increase in cases during the Omicron wave at the city and provincial levels shows a decoupling of cases and deaths compared to previous waves, corroborating the clinical findings of decreased severity of disease seen in patients admitted to the Steve Biko Academic Hospital. There was decreased severity of COVID-19 disease in the Omicron-driven fourth wave in the City of Tshwane, its first global epicentre. The coronavirus disease 2019 (COVID-19) first reported in Wuhan, China in December 2019 is a global pandemic that is threatening the health and wellbeing of people worldwide. To date there have been more than 274 million reported cases and 5.3 million deaths. The Omicron variant first documented in the City of Tshwane, Gauteng Province, South Africa on 9 November 2021 led to exponential increases in cases and a sharp rise in hospital admissions. The clinical profile of patients admitted at a large hospital in Tshwane is compared with previous waves.INTRODUCTIONThe coronavirus disease 2019 (COVID-19) first reported in Wuhan, China in December 2019 is a global pandemic that is threatening the health and wellbeing of people worldwide. To date there have been more than 274 million reported cases and 5.3 million deaths. The Omicron variant first documented in the City of Tshwane, Gauteng Province, South Africa on 9 November 2021 led to exponential increases in cases and a sharp rise in hospital admissions. The clinical profile of patients admitted at a large hospital in Tshwane is compared with previous waves.466 hospital COVID-19 admissions since 14 November 2021 were compared to 3962 admissions since 4 May 2020, prior to the Omicron outbreak. Ninety-eight patient records at peak bed occupancy during the outbreak were reviewed for primary indication for admission, clinical severity, oxygen supplementation level, vaccination and prior COVID-19 infection. Provincial and city-wide daily cases and reported deaths, hospital admissions and excess deaths data were sourced from the National Institute for Communicable Diseases, the National Department of Health and the South African Medical Research Council.METHODS466 hospital COVID-19 admissions since 14 November 2021 were compared to 3962 admissions since 4 May 2020, prior to the Omicron outbreak. Ninety-eight patient records at peak bed occupancy during the outbreak were reviewed for primary indication for admission, clinical severity, oxygen supplementation level, vaccination and prior COVID-19 infection. Provincial and city-wide daily cases and reported deaths, hospital admissions and excess deaths data were sourced from the National Institute for Communicable Diseases, the National Department of Health and the South African Medical Research Council.For the Omicron and previous waves, deaths and ICU admissions were 4.5% vs 21.3% (p<0.00001), and 1% vs 4.3% (p<0.00001) respectively; length of stay was 4.0 days vs 8.8 days; and mean age was 39 years vs 49,8 years. Admissions in the Omicron wave peaked and declined rapidly with peak bed occupancy at 51% of the highest previous peak during the Delta wave. Sixty two (63%) patients in COVID-19 wards had incidental COVID-19 following a positive SARS-CoV-2 PCR test . Only one third (36) had COVID-19 pneumonia, of which 72% had mild to moderate disease. The remaining 28% required high care or ICU admission. Fewer than half (45%) of patients in COVID-19 wards required oxygen supplementation compared to 99.5% in the first wave. The death rate in the face of an exponential increase in cases during the Omicron wave at the city and provincial levels shows a decoupling of cases and deaths compared to previous waves, corroborating the clinical findings of decreased severity of disease seen in patients admitted to the Steve Biko Academic Hospital.RESULTSFor the Omicron and previous waves, deaths and ICU admissions were 4.5% vs 21.3% (p<0.00001), and 1% vs 4.3% (p<0.00001) respectively; length of stay was 4.0 days vs 8.8 days; and mean age was 39 years vs 49,8 years. Admissions in the Omicron wave peaked and declined rapidly with peak bed occupancy at 51% of the highest previous peak during the Delta wave. Sixty two (63%) patients in COVID-19 wards had incidental COVID-19 following a positive SARS-CoV-2 PCR test . Only one third (36) had COVID-19 pneumonia, of which 72% had mild to moderate disease. The remaining 28% required high care or ICU admission. Fewer than half (45%) of patients in COVID-19 wards required oxygen supplementation compared to 99.5% in the first wave. The death rate in the face of an exponential increase in cases during the Omicron wave at the city and provincial levels shows a decoupling of cases and deaths compared to previous waves, corroborating the clinical findings of decreased severity of disease seen in patients admitted to the Steve Biko Academic Hospital.There was decreased severity of COVID-19 disease in the Omicron-driven fourth wave in the City of Tshwane, its first global epicentre.CONCLUSIONThere was decreased severity of COVID-19 disease in the Omicron-driven fourth wave in the City of Tshwane, its first global epicentre. •the rapid rise and decline of admissions and decreased severity of COVID-19 disease•compares 466 patients in the Omicron wave to 3962 patients in previous waves•describes disease severity of all admitted patients at peak bed occupancy•a lower mortality rate from Omicron compared to previous waves The coronavirus disease 2019 (COVID-19) first reported in Wuhan, China in December 2019 is a global pandemic that is threatening the health and wellbeing of people worldwide. To date there have been more than 274 million reported cases and 5.3 million deaths. The Omicron variant first documented in the City of Tshwane, Gauteng Province, South Africa on 9 November 2021 led to exponential increases in cases and a sharp rise in hospital admissions. The clinical profile of patients admitted at a large hospital in Tshwane is compared with previous waves. 466 hospital COVID-19 admissions since 14 November 2021 were compared to 3962 admissions since 4 May 2020, prior to the Omicron outbreak. Ninety-eight patient records at peak bed occupancy during the outbreak were reviewed for primary indication for admission, clinical severity, oxygen supplementation level, vaccination and prior COVID-19 infection. Provincial and city-wide daily cases and reported deaths, hospital admissions and excess deaths data were sourced from the National Institute for Communicable Diseases, the National Department of Health and the South African Medical Research Council. For the Omicron and previous waves, deaths and ICU admissions were 4.5% vs 21.3% (p<0.00001), and 1% vs 4.3% (p<0.00001) respectively; length of stay was 4.0 days vs 8.8 days; and mean age was 39 years vs 49,8 years. Admissions in the Omicron wave peaked and declined rapidly with peak bed occupancy at 51% of the highest previous peak during the Delta wave. Sixty two (63%) patients in COVID-19 wards had incidental COVID-19 following a positive SARS-CoV-2 PCR test . Only one third (36) had COVID-19 pneumonia, of which 72% had mild to moderate disease. The remaining 28% required high care or ICU admission. Fewer than half (45%) of patients in COVID-19 wards required oxygen supplementation compared to 99.5% in the first wave. The death rate in the face of an exponential increase in cases during the Omicron wave at the city and provincial levels shows a decoupling of cases and deaths compared to previous waves, corroborating the clinical findings of decreased severity of disease seen in patients admitted to the Steve Biko Academic Hospital. There was decreased severity of COVID-19 disease in the Omicron-driven fourth wave in the City of Tshwane, its first global epicentre. |
Author | Ueckermann, V. Soma-Pillay, P. Gray, G. Welch, R. Ramlall, R. Abdullah, F. Mathebula, M. Spoor, S. Paruk, F. Boswell, M.T. Jassat, W. Cloete, J. Myburg, M. Van der Walt, Z. Basu, D. de Villiers, T. Lalloo, V. Myers, J. van Hougenhouck-Tulleken, W. Rheeder, P. Kistan, J. Blumberg, L. Tintinger, G. Engelbrecht, A. |
Author_xml | – sequence: 1 givenname: F. orcidid: 0000-0002-1118-9430 surname: Abdullah fullname: Abdullah, F. organization: Division of Infectious Diseases, Steve Biko Academic Hospital – sequence: 2 givenname: J. orcidid: 0000-0002-3939-4874 surname: Myers fullname: Myers, J. organization: School of Public Health and Family Medicine, Faculty of Health Sciences, University of Cape Town – sequence: 3 givenname: D. orcidid: 0000-0002-4117-6817 surname: Basu fullname: Basu, D. organization: Department of Public Health Medicine, University of Pretoria – sequence: 4 givenname: G. surname: Tintinger fullname: Tintinger, G. organization: Department of Internal Medicine, Steve Biko Academic Hospital and University of Pretoria – sequence: 5 givenname: V. orcidid: 0000-0002-4419-3583 surname: Ueckermann fullname: Ueckermann, V. organization: Division of Infectious Diseases, Steve Biko Academic Hospital – sequence: 6 givenname: M. surname: Mathebula fullname: Mathebula, M. organization: Steve Biko Academic Hospital – sequence: 7 givenname: R. surname: Ramlall fullname: Ramlall, R. organization: Tshwane District Hospital – sequence: 8 givenname: S. surname: Spoor fullname: Spoor, S. organization: Tshwane District Hospital – sequence: 9 givenname: T. surname: de Villiers fullname: de Villiers, T. organization: Tshwane District Hospital – sequence: 10 givenname: Z. surname: Van der Walt fullname: Van der Walt, Z. organization: Tshwane District Hospital – sequence: 11 givenname: J. orcidid: 0000-0001-6548-2475 surname: Cloete fullname: Cloete, J. organization: Department of Paediatrics, Steve Biko Academic Hospital and University of Pretoria – sequence: 12 givenname: P. surname: Soma-Pillay fullname: Soma-Pillay, P. organization: Department of Obstetrics, Steve Biko Academic Hospital and University of Pretoria – sequence: 13 givenname: P. surname: Rheeder fullname: Rheeder, P. organization: Department of Internal Medicine, Steve Biko Academic Hospital and University of Pretoria – sequence: 14 givenname: F. orcidid: 0000-0002-6549-0106 surname: Paruk fullname: Paruk, F. organization: Department of Critical Care, Steve Biko Academic Hospital and University of Pretoria – sequence: 15 givenname: A. surname: Engelbrecht fullname: Engelbrecht, A. organization: Department of Emergency Medicine, Steve Biko Academic Hospital and University of Pretoria – sequence: 16 givenname: V. orcidid: 0000-0002-5547-8461 surname: Lalloo fullname: Lalloo, V. organization: Department of Emergency Medicine, Steve Biko Academic Hospital and University of Pretoria – sequence: 17 givenname: M. surname: Myburg fullname: Myburg, M. organization: Steve Biko Academic Hospital – sequence: 18 givenname: J. orcidid: 0000-0002-9446-0918 surname: Kistan fullname: Kistan, J. organization: Department of Public Health Medicine, University of Pretoria – sequence: 19 givenname: W. surname: van Hougenhouck-Tulleken fullname: van Hougenhouck-Tulleken, W. organization: Department of Internal Medicine, Steve Biko Academic Hospital and University of Pretoria – sequence: 20 givenname: M.T. surname: Boswell fullname: Boswell, M.T. organization: Department of Internal Medicine, Steve Biko Academic Hospital and University of Pretoria – sequence: 21 givenname: G. surname: Gray fullname: Gray, G. organization: South African Medical Research Council – sequence: 22 givenname: R. surname: Welch fullname: Welch, R. organization: National Institute of Communicable Diseases – sequence: 23 givenname: L. surname: Blumberg fullname: Blumberg, L. organization: National Institute of Communicable Diseases – sequence: 24 givenname: W. surname: Jassat fullname: Jassat, W. organization: National Institute of Communicable Diseases |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/34971823$$D View this record in MEDLINE/PubMed |
BookMark | eNqFUk1v1DAUjFAR_YA_wAH5yIEsfk6cOAghofJVqRIXOFuO87z7ttm42N5Fe-eH47Cloj2Uk63xzDzrzZwWR5OfsCieA18Ah-b1ekFrGhaCC1iAWFSyfVScgGpVWUmAo3wXHMquBXFcnMa45pzXTaOeFMdVnVElqpPi1we0AU3EgUXcYaC0Z96xgeIMsmEbaFqytELmKMTElqPvzcj8hmzwE9uZQGZKzPodDSV0zG9Tn_2uGE3MsNGEJbKVj9eUsipjKa5-mglfsZiZK2ZcIGueFo-dGSM-uznPiu-fPn47_1Jefv18cf7-srRNpVIpmx4GKXveVJ1oueLCQOfACOsU1iihQwFGysE5rJSTGVFDLYFbYbAXsjorLg6-gzdrfR1oY8Jee0P6D-DDUpuQyI6oFUKPvZV5eVgr1Rrr8pDWyQZtVWGfvd4dvK63_QYHi1MKZrxjevdlopVe-p1WLVQ1NNng5Y1B8D-2GJPeULQ4jnk9fhu1aEB20Eo5U1_8O-t2yN8YM0EcCDmUGAO6WwpwPXdFr_XcFT13RYPQuStZpO6JbE4pkZ__S-PD0rcHKea0doRBR0s4WRwooE15nfSw_M09uR1pykUYr3D_P_FvgaHwRw |
CitedBy_id | crossref_primary_10_1111_eci_14004 crossref_primary_10_1016_j_semerg_2023_102073 crossref_primary_10_1109_TASE_2022_3224171 crossref_primary_10_1136_bmjopen_2022_061752 crossref_primary_10_47203_IJCH_2022_v34i02_006 crossref_primary_10_1016_j_clrc_2024_100194 crossref_primary_10_1016_j_msard_2022_103803 crossref_primary_10_2139_ssrn_4053482 crossref_primary_10_1016_j_gloepi_2024_100181 crossref_primary_10_7759_cureus_41200 crossref_primary_10_1080_22221751_2023_2276338 crossref_primary_10_1001_jamanetworkopen_2022_26436 crossref_primary_10_1016_j_gene_2024_148970 crossref_primary_10_1016_j_medcle_2022_05_017 crossref_primary_10_7759_cureus_25196 crossref_primary_10_3390_jcm12185904 crossref_primary_10_1620_tjem_2022_J067 crossref_primary_10_1016_j_resinv_2022_08_001 crossref_primary_10_1186_s12985_024_02538_0 crossref_primary_10_3390_jcm11144038 crossref_primary_10_1080_13814788_2022_2154074 crossref_primary_10_2217_fvl_2022_0003 crossref_primary_10_3389_fmicb_2022_854567 crossref_primary_10_1186_s12880_022_00833_2 crossref_primary_10_1016_j_medcli_2022_05_010 crossref_primary_10_1093_infdis_jiad057 crossref_primary_10_1001_jamanetworkopen_2023_9050 crossref_primary_10_1007_s11684_023_1043_5 crossref_primary_10_1016_j_pediatrneurol_2024_01_008 crossref_primary_10_1177_14034948221108548 crossref_primary_10_1128_jvi_00961_22 crossref_primary_10_1055_s_0042_1751312 crossref_primary_10_1111_imm_13487 crossref_primary_10_3389_fmed_2023_1079165 crossref_primary_10_3389_fimmu_2022_914167 crossref_primary_10_1016_S1473_3099_22_00154_2 crossref_primary_10_3389_fpubh_2023_1143650 crossref_primary_10_1111_jocn_16721 crossref_primary_10_5588_ijtldopen_23_0053 crossref_primary_10_22207_JPAM_16_3_45 crossref_primary_10_4102_jtscm_v17i0_881 crossref_primary_10_1177_23814683231222469 crossref_primary_10_3390_ijms231911291 crossref_primary_10_3389_fmed_2023_1256080 crossref_primary_10_3390_ijms23041987 crossref_primary_10_3390_ijerph20042779 crossref_primary_10_1016_j_jiac_2022_09_005 crossref_primary_10_1186_s12916_023_03235_5 crossref_primary_10_5582_bst_2022_01062 crossref_primary_10_3389_fimmu_2022_1010140 crossref_primary_10_17816_clinpract322036 crossref_primary_10_1002_rmv_2398 crossref_primary_10_2139_ssrn_4065233 crossref_primary_10_1016_j_idnow_2023_104713 crossref_primary_10_1080_21645515_2024_2436714 crossref_primary_10_1186_s12887_025_05524_9 crossref_primary_10_4236_aid_2022_123042 crossref_primary_10_1016_j_mran_2022_100217 crossref_primary_10_1016_j_jiph_2023_01_013 crossref_primary_10_1186_s12985_024_02531_7 crossref_primary_10_1002_iid3_606 crossref_primary_10_1136_bmjopen_2023_076959 crossref_primary_10_1017_ice_2024_3 crossref_primary_10_25259_JRHM_11_2022 crossref_primary_10_2169_internalmedicine_1399_22 crossref_primary_10_2478_slgr_2023_0004 crossref_primary_10_1186_s41479_022_00099_w crossref_primary_10_3390_vaccines10060940 crossref_primary_10_1007_s00268_023_07222_y crossref_primary_10_1111_anae_15699 crossref_primary_10_1186_s40001_024_01840_5 crossref_primary_10_1016_j_virs_2022_07_014 crossref_primary_10_1016_j_scitotenv_2022_158028 crossref_primary_10_1186_s12879_025_10585_3 crossref_primary_10_1089_aid_2022_0048 crossref_primary_10_1001_jamanetworkopen_2022_46152 crossref_primary_10_12677_AMB_2022_112006 crossref_primary_10_3390_v14112377 crossref_primary_10_3390_v14112499 crossref_primary_10_1016_j_ceh_2023_10_002 crossref_primary_10_1093_ofid_ofac262 crossref_primary_10_3390_v14122736 crossref_primary_10_5662_wjm_v14_i3_89761 crossref_primary_10_7883_yoken_JJID_2024_071 crossref_primary_10_1177_17534666231209150 crossref_primary_10_1097_MD_0000000000029165 crossref_primary_10_3390_vaccines10111901 crossref_primary_10_4081_monaldi_2022_2324 crossref_primary_10_3390_diagnostics13030559 crossref_primary_10_58318_2957_5702_2022_9_44_54 crossref_primary_10_29235_1814_6023_2023_20_1_34_41 crossref_primary_10_3390_organoids1010002 crossref_primary_10_1016_j_jinf_2022_10_004 crossref_primary_10_1186_s12916_023_03234_6 crossref_primary_10_1016_j_ijid_2022_03_023 crossref_primary_10_1186_s12879_022_07777_6 crossref_primary_10_1016_j_lansea_2022_100023 crossref_primary_10_57187_s_3636 crossref_primary_10_1186_s12885_024_13020_z crossref_primary_10_1007_s10753_022_01734_w crossref_primary_10_2147_RMHP_S375021 crossref_primary_10_1080_22221751_2022_2093135 crossref_primary_10_1093_oncolo_oyad121 crossref_primary_10_1016_j_ijregi_2022_11_008 crossref_primary_10_4103_ed_ed_5_22 crossref_primary_10_1177_2632010X221124908 crossref_primary_10_1001_jamanetworkopen_2022_55599 crossref_primary_10_4081_monaldi_2022_2337 crossref_primary_10_1245_s10434_024_16297_3 crossref_primary_10_1038_s41467_022_35480_2 crossref_primary_10_1038_s41577_022_00720_5 crossref_primary_10_1080_07853890_2023_2274510 crossref_primary_10_3390_healthcare11121703 crossref_primary_10_23736_S2784_8477_23_02103_4 crossref_primary_10_7759_cureus_48046 crossref_primary_10_1111_apa_16576 crossref_primary_10_22159_ijcpr_2024v16i6_6014 crossref_primary_10_3389_fimmu_2022_856072 crossref_primary_10_1007_s40259_022_00529_7 crossref_primary_10_1016_j_eclinm_2022_101455 crossref_primary_10_1097_MAT_0000000000002334 crossref_primary_10_3390_biom12101353 crossref_primary_10_1007_s40520_023_02415_w crossref_primary_10_1080_03007995_2023_2223917 crossref_primary_10_1093_infdis_jiac411 crossref_primary_10_3390_biom12050631 crossref_primary_10_4049_jimmunol_2200175 crossref_primary_10_4103_JME_JME_80_22 crossref_primary_10_4103_jacp_jacp_4_22 crossref_primary_10_1371_journal_pone_0281326 crossref_primary_10_1002_ccr3_5934 crossref_primary_10_1016_j_eimc_2022_11_003 crossref_primary_10_3389_fmicb_2022_923546 crossref_primary_10_3389_fimmu_2023_1257360 crossref_primary_10_1016_j_ijid_2023_01_030 crossref_primary_10_3390_ijms23169058 crossref_primary_10_1371_journal_pone_0291580 crossref_primary_10_1016_j_cell_2023_08_026 crossref_primary_10_1038_s41598_024_60841_w crossref_primary_10_3346_jkms_2022_37_e246 crossref_primary_10_3390_zoonoticdis4040023 crossref_primary_10_1038_s41598_022_21690_7 crossref_primary_10_1016_j_jiac_2022_08_004 crossref_primary_10_1053_j_jvca_2025_02_015 crossref_primary_10_2217_fon_2022_0024 crossref_primary_10_36604_1998_5029_2023_88_59_68 crossref_primary_10_15585_mmwr_mm7106e2 crossref_primary_10_3390_antibiotics12020393 crossref_primary_10_1002_jmv_28214 crossref_primary_10_1111_irv_13019 crossref_primary_10_1371_journal_pone_0276774 crossref_primary_10_1016_j_envres_2022_114446 crossref_primary_10_4103_jalh_jalh_38_23 crossref_primary_10_1186_s44158_022_00058_3 crossref_primary_10_1111_anae_16061 crossref_primary_10_1186_s12864_024_10973_0 crossref_primary_10_3389_fmicb_2022_1061879 crossref_primary_10_1016_j_ijid_2023_02_020 crossref_primary_10_1186_s12879_022_07941_y crossref_primary_10_1126_scitranslmed_abm2311 crossref_primary_10_1186_s40246_022_00392_1 crossref_primary_10_1016_j_cell_2022_03_038 crossref_primary_10_1016_j_arbres_2022_06_001 crossref_primary_10_1080_22221751_2022_2103455 crossref_primary_10_1016_j_virs_2022_02_001 crossref_primary_10_3390_v14061297 crossref_primary_10_3390_biomedicines11082113 crossref_primary_10_3892_etm_2024_12372 crossref_primary_10_1016_j_ijid_2022_07_005 crossref_primary_10_3389_fimmu_2022_1094727 crossref_primary_10_1016_j_genrep_2022_101549 crossref_primary_10_2144_fsoa_2023_0024 crossref_primary_10_1016_j_jfma_2024_11_016 crossref_primary_10_3390_biomedicines11041143 crossref_primary_10_1002_mco2_172 crossref_primary_10_1016_S2352_4642_22_00060_8 crossref_primary_10_22207_JPAM_17_3_46 crossref_primary_10_3390_vaccines12121303 crossref_primary_10_1016_j_hbpd_2024_01_001 crossref_primary_10_1038_s41392_022_00997_x crossref_primary_10_1016_j_ijmmb_2022_12_004 crossref_primary_10_1136_bmjgh_2023_012328 crossref_primary_10_1016_j_biopha_2022_112767 crossref_primary_10_3389_fpubh_2022_903568 crossref_primary_10_1002_jmv_28477 crossref_primary_10_1016_j_ijid_2022_04_029 crossref_primary_10_3390_vaccines10081362 crossref_primary_10_2147_IJGM_S391024 crossref_primary_10_3389_fimmu_2024_1359380 crossref_primary_10_3390_v14061181 crossref_primary_10_1016_j_xcrm_2023_101361 crossref_primary_10_1155_2023_8846953 crossref_primary_10_2139_ssrn_4289504 crossref_primary_10_3389_fmicb_2024_1334152 crossref_primary_10_1111_petr_14235 crossref_primary_10_1007_s12033_023_00919_4 crossref_primary_10_1097_YIC_0000000000000491 crossref_primary_10_1093_cid_ciac705 crossref_primary_10_3346_jkms_2024_39_e150 crossref_primary_10_3389_fpubh_2022_1014470 crossref_primary_10_3390_vaccines11010126 crossref_primary_10_1002_ijgo_14934 crossref_primary_10_1186_s12913_025_12482_6 crossref_primary_10_3390_md20020148 crossref_primary_10_3389_fpubh_2024_1294261 crossref_primary_10_1016_j_eimce_2022_11_021 crossref_primary_10_1016_j_jiph_2022_12_003 crossref_primary_10_15585_mmwr_mm7104e4 crossref_primary_10_3390_vaccines12060645 crossref_primary_10_1016_j_cmi_2023_03_017 crossref_primary_10_1155_2023_4940767 crossref_primary_10_1016_j_jinf_2024_106121 crossref_primary_10_15407_fz69_01_035 crossref_primary_10_3390_diagnostics12082010 crossref_primary_10_3390_jcm13123477 crossref_primary_10_1016_S2352_4642_22_00059_1 crossref_primary_10_1016_j_anzjph_2024_100170 crossref_primary_10_1371_journal_pone_0268734 crossref_primary_10_32997_rcb_2022_3778 crossref_primary_10_1128_jvi_01351_23 crossref_primary_10_1080_02640414_2024_2312054 crossref_primary_10_1080_14656566_2023_2262387 crossref_primary_10_1001_jamaoncol_2023_2271 crossref_primary_10_13105_wjma_v10_i3_177 crossref_primary_10_3390_children9071043 crossref_primary_10_1038_s41467_024_46692_z crossref_primary_10_1002_ijgo_14348 crossref_primary_10_3389_fepid_2022_891162 crossref_primary_10_3390_ijms25147537 crossref_primary_10_1016_j_radcr_2022_06_034 crossref_primary_10_4178_epih_e2022034 crossref_primary_10_2147_IDR_S380005 crossref_primary_10_1177_03000605221086433 crossref_primary_10_37737_ace_23005 crossref_primary_10_1292_jvms_23_0205 crossref_primary_10_1016_j_lfs_2022_120392 crossref_primary_10_3892_etm_2022_11343 crossref_primary_10_1038_s41467_022_31200_y crossref_primary_10_1093_cid_ciac802 crossref_primary_10_1002_acn3_51833 crossref_primary_10_1016_j_ijregi_2022_07_005 crossref_primary_10_24018_ejmed_2022_4_3_1258 crossref_primary_10_3390_ijms241411614 crossref_primary_10_3390_v15010149 crossref_primary_10_1055_a_1956_9641 crossref_primary_10_1002_jmv_27613 crossref_primary_10_1016_j_ebiom_2023_104924 crossref_primary_10_1021_acsmaterialslett_3c01442 crossref_primary_10_1186_s12871_024_02600_y crossref_primary_10_3390_v15030618 crossref_primary_10_2147_IJGM_S429870 crossref_primary_10_1002_jmv_28034 crossref_primary_10_1002_jmv_28831 crossref_primary_10_1002_jso_27425 crossref_primary_10_1186_s13059_023_02881_5 crossref_primary_10_1056_NEJMoa2203209 crossref_primary_10_1080_14787210_2022_2077191 crossref_primary_10_3389_fimmu_2023_1189482 crossref_primary_10_7326_M22_0308 crossref_primary_10_3389_fpubh_2022_876551 crossref_primary_10_30934_kusbed_1060956 crossref_primary_10_1016_j_bbadis_2022_166582 crossref_primary_10_1016_j_hbpd_2024_09_009 crossref_primary_10_2147_JIR_S420721 crossref_primary_10_2147_IDR_S450504 crossref_primary_10_1016_j_legalmed_2023_102222 crossref_primary_10_1515_cclm_2022_1287 crossref_primary_10_3390_v16040649 crossref_primary_10_1016_S0140_6736_22_00462_7 crossref_primary_10_3390_jcm11247452 crossref_primary_10_3390_tropicalmed9110266 crossref_primary_10_1016_j_jhin_2023_01_018 crossref_primary_10_1080_22221751_2022_2095932 crossref_primary_10_1016_S2214_109X_22_00359_X crossref_primary_10_1016_j_bjid_2024_103721 crossref_primary_10_3390_microorganisms10040806 crossref_primary_10_1093_ofid_ofac502 crossref_primary_10_3892_etm_2023_12097 crossref_primary_10_1016_j_mayocpiqo_2023_07_004 crossref_primary_10_1371_journal_pone_0282806 crossref_primary_10_1186_s42269_022_00879_w crossref_primary_10_3390_ijerph191912019 crossref_primary_10_1002_jmv_29143 crossref_primary_10_1038_s41586_021_04387_1 crossref_primary_10_3390_children9101542 |
Cites_doi | 10.1101/2021.12.20.21268096 10.21203/rs.3.rs-1156502/v1 |
ContentType | Journal Article |
Copyright | 2021 The Author(s) Copyright © 2021 The Author(s). Published by Elsevier Ltd.. All rights reserved. 2021 The Author(s) 2021 |
Copyright_xml | – notice: 2021 The Author(s) – notice: Copyright © 2021 The Author(s). Published by Elsevier Ltd.. All rights reserved. – notice: 2021 The Author(s) 2021 |
DBID | 6I. AAFTH AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 5PM DOA |
DOI | 10.1016/j.ijid.2021.12.357 |
DatabaseName | ScienceDirect Open Access Titles Elsevier:ScienceDirect:Open Access CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Public Health |
EISSN | 1878-3511 |
EndPage | 42 |
ExternalDocumentID | oai_doaj_org_article_8e1bebc5712e4887acff8e7f56ec33eb PMC8713416 34971823 10_1016_j_ijid_2021_12_357 S120197122101256X |
Genre | Journal Article |
GeographicLocations | South Africa |
GeographicLocations_xml | – name: South Africa |
GroupedDBID | --- --K .1- .FO .~1 0R~ 1B1 1P~ 1~. 1~5 29J 3O- 4.4 457 4G. 53G 5GY 5VS 7-5 71M 7X7 88E 8C1 8FI 8FJ 8FQ 8R4 8R5 AAEDW AAFWJ AAIKJ AALRI AAQFI AAQXK AARKO AAXUO AAYWO ABBQC ABFRF ABMAC ABUWG ABWVN ACGFO ACRPL ACVFH ADBBV ADCNI ADEZE ADMUD ADNMO ADVLN AEFWE AEKER AENEX AEUPX AEVXI AEXQZ AFJKZ AFKRA AFPKN AFPUW AFRHN AFTJW AGEKW AGHFR AGQPQ AGYEJ AHMBA AIGII AITUG AJRQY AJUYK AKBMS AKRWK AKYEP ALMA_UNASSIGNED_HOLDINGS AMRAJ APXCP ASPBG AVWKF AZFZN BAWUL BCNDV BENPR BPHCQ BR6 BVXVI CCPQU CS3 DIK DU5 DWQXO E3Z EBS EJD EO8 EO9 EP2 EP3 F5P FDB FEDTE FGOYB FNPLU FYUFA G-Q GBLVA GROUPED_DOAJ GX1 HMCUK HVGLF HZ~ IHE IXB J1W KQ8 M1P M3C M3G M41 MO0 N9A O-L O9- OD- OK1 OO. OZT P-8 P-9 P2P PC. PHGZM PHGZT PJZUB PPXIY PQQKQ PROAC PSQYO PUEGO Q2X Q38 QTD R2- ROL RPZ RWL RXW SDF SDG SEL SES SEW SSZ TAE UKHRP UNMZH Z5R 0SF 3V. 6I. AACTN AAFTH ABVKL AFCTW NCXOZ RIG AAYXX ALIPV CITATION CGR CUY CVF ECM EIF NPM 7X8 5PM |
ID | FETCH-LOGICAL-c638t-56b1d55b0639270802a19f1a2cf8e4e519e21a55dffe38f5e518d4510c2aeb253 |
IEDL.DBID | DOA |
ISSN | 1201-9712 1878-3511 |
IngestDate | Wed Aug 27 01:32:00 EDT 2025 Thu Aug 21 18:45:39 EDT 2025 Fri Jul 11 00:17:10 EDT 2025 Thu Apr 24 04:15:05 EDT 2025 Thu Apr 24 23:07:04 EDT 2025 Tue Jul 01 04:30:10 EDT 2025 Fri Feb 23 02:40:11 EST 2024 Tue Aug 26 16:32:04 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Keywords | SAMRC SBAH COVID-19 Tshwane NICD South Africa NDOH UP Omicron disease severity |
Language | English |
License | This is an open access article under the CC BY-NC-ND license. Copyright © 2021 The Author(s). Published by Elsevier Ltd.. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c638t-56b1d55b0639270802a19f1a2cf8e4e519e21a55dffe38f5e518d4510c2aeb253 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ORCID | 0000-0002-4117-6817 0000-0002-3939-4874 0000-0002-4419-3583 0000-0002-6549-0106 0000-0002-9446-0918 0000-0002-5547-8461 0000-0001-6548-2475 0000-0002-1118-9430 |
OpenAccessLink | https://doaj.org/article/8e1bebc5712e4887acff8e7f56ec33eb |
PMID | 34971823 |
PQID | 2615917556 |
PQPubID | 23479 |
PageCount | 5 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_8e1bebc5712e4887acff8e7f56ec33eb pubmedcentral_primary_oai_pubmedcentral_nih_gov_8713416 proquest_miscellaneous_2615917556 pubmed_primary_34971823 crossref_primary_10_1016_j_ijid_2021_12_357 crossref_citationtrail_10_1016_j_ijid_2021_12_357 elsevier_sciencedirect_doi_10_1016_j_ijid_2021_12_357 elsevier_clinicalkey_doi_10_1016_j_ijid_2021_12_357 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2022-03-01 |
PublicationDateYYYYMMDD | 2022-03-01 |
PublicationDate_xml | – month: 03 year: 2022 text: 2022-03-01 day: 01 |
PublicationDecade | 2020 |
PublicationPlace | Canada |
PublicationPlace_xml | – name: Canada |
PublicationTitle | International journal of infectious diseases |
PublicationTitleAlternate | Int J Infect Dis |
PublicationYear | 2022 |
Publisher | Elsevier Ltd The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases Elsevier |
Publisher_xml | – name: Elsevier Ltd – name: The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases – name: Elsevier |
References | (accessed 20 December 2021) 2021 (accessed Dec 10, 2021) 2021 Bradshaw D. et al. Estimated natural deaths of persons 1+years. South Africa Medical Research Council. Stata/IC 16. 1 for Mac Revision 31 Mar 2020 Boswell T. et al. COVID-19 severity and in-hospital mortality in an area with high HIV prevalence, 09 December 2021, PREPRINT (Version 1) available at Research Square [ https://doi.org/10.21203/rs.3.rs-1156502/v1 ] accessed 23 December 2021 World Health Organisation. Mendelsohn (bib0004) 2021 (accessed 22 December 2021) 2021. Maslo (bib13) 2021 COVID-19 Wkly. Epidemiol. BRIEF, WEEK 48 2021. https://www.nicd.ac.za/wp-content/uploads/2021/12/COVID-19-Weekly-Epidemiology-Brief-week-48-2021.pdf (accessed 20 December 2021) 2021. National Department of Health. COVID-19 statistics in South Africa. (accessed 11 December 2021) 2021 Viana R. et al. Rapid epidemic expansion of the SARS-CoV-2 Omicron variant in southern Africa. medRxiv, MEDRXIV-2021-268028v1-deOliveira: (2021). World Health Organization. Classification of Omicron (B.1.1.529): SARS-CoV-2 Variant of Concern. National Institute for Communicable Diseases. Network for Genomics Surveillance in South Africa (NGS-SA). SARS-CoV-2 Genomic Surveillance Update. (accessed 20 December 2021) 2021. Madhi Shabir A., et al. South African Population Immunity and Severe Covid-19 with Omicron Variant. Shabir A. Madhi, et al 2021 Office of the Executive Mayor 10.1016/j.ijid.2021.12.357_bib0009 10.1016/j.ijid.2021.12.357_bib0005 10.1016/j.ijid.2021.12.357_bib0006 10.1016/j.ijid.2021.12.357_bib0007 10.1016/j.ijid.2021.12.357_bib0008 10.1016/j.ijid.2021.12.357_bib0001 Maslo (10.1016/j.ijid.2021.12.357_bib13) 2021 10.1016/j.ijid.2021.12.357_bib0012 10.1016/j.ijid.2021.12.357_bib0002 Mendelsohn (10.1016/j.ijid.2021.12.357_bib0004) 2021 10.1016/j.ijid.2021.12.357_bib0003 10.1016/j.ijid.2021.12.357_bib0010 10.1016/j.ijid.2021.12.357_bib0011 |
References_xml | – reference: (accessed 20 December 2021) 2021 – reference: (accessed 11 December 2021) 2021 – reference: Stata/IC 16. 1 for Mac Revision 31 Mar 2020 – reference: (accessed 23 December 2021) – reference: Network for Genomics Surveillance in South Africa (NGS-SA). SARS-CoV-2 Genomic Surveillance Update. – reference: (accessed 20 December 2021) 2021. – year: 2021 ident: bib13 publication-title: JAMA – reference: National Institute for Communicable Diseases. – reference: (accessed Dec 10, 2021) 2021 – reference: (accessed 22 December 2021) 2021. – reference: Boswell T. et al. COVID-19 severity and in-hospital mortality in an area with high HIV prevalence, 09 December 2021, PREPRINT (Version 1) available at Research Square [ https://doi.org/10.21203/rs.3.rs-1156502/v1 ] – reference: National Department of Health. COVID-19 statistics in South Africa. – reference: . COVID-19 Wkly. Epidemiol. BRIEF, WEEK 48 2021. https://www.nicd.ac.za/wp-content/uploads/2021/12/COVID-19-Weekly-Epidemiology-Brief-week-48-2021.pdf (accessed 20 December 2021) 2021. – reference: Office of the Executive Mayor – reference: Viana R. et al. Rapid epidemic expansion of the SARS-CoV-2 Omicron variant in southern Africa. medRxiv, MEDRXIV-2021-268028v1-deOliveira: (2021). – reference: World Health Organization. Classification of Omicron (B.1.1.529): SARS-CoV-2 Variant of Concern. – year: 2021 ident: bib0004 article-title: COVID-19 wave 4 in Western Cape Province, South Africa: Fewer hospitalisations, but new challenges for a depleted workforce publication-title: S Afr Med J. – reference: Madhi Shabir A., et al. South African Population Immunity and Severe Covid-19 with Omicron Variant. Shabir A. Madhi, et al 2021, – reference: Bradshaw D. et al. Estimated natural deaths of persons 1+years. South Africa Medical Research Council. – reference: World Health Organisation. – ident: 10.1016/j.ijid.2021.12.357_bib0003 doi: 10.1101/2021.12.20.21268096 – ident: 10.1016/j.ijid.2021.12.357_bib0011 – ident: 10.1016/j.ijid.2021.12.357_bib0010 – ident: 10.1016/j.ijid.2021.12.357_bib0012 – year: 2021 ident: 10.1016/j.ijid.2021.12.357_bib13 publication-title: JAMA – ident: 10.1016/j.ijid.2021.12.357_bib0005 – ident: 10.1016/j.ijid.2021.12.357_bib0001 doi: 10.21203/rs.3.rs-1156502/v1 – year: 2021 ident: 10.1016/j.ijid.2021.12.357_bib0004 article-title: COVID-19 wave 4 in Western Cape Province, South Africa: Fewer hospitalisations, but new challenges for a depleted workforce publication-title: S Afr Med J. – ident: 10.1016/j.ijid.2021.12.357_bib0006 – ident: 10.1016/j.ijid.2021.12.357_bib0007 – ident: 10.1016/j.ijid.2021.12.357_bib0008 – ident: 10.1016/j.ijid.2021.12.357_bib0009 – ident: 10.1016/j.ijid.2021.12.357_bib0002 |
SSID | ssj0004668 |
Score | 2.68172 |
Snippet | •the rapid rise and decline of admissions and decreased severity of COVID-19 disease•compares 466 patients in the Omicron wave to 3962 patients in previous... The coronavirus disease 2019 (COVID-19) first reported in Wuhan, China in December 2019 is a global pandemic that is threatening the health and wellbeing of... INTRODUCTION: The coronavirus disease 2019 (COVID-19) first reported in Wuhan, China in December 2019 is a global pandemic that is threatening the health and... |
SourceID | doaj pubmedcentral proquest pubmed crossref elsevier |
SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 38 |
SubjectTerms | Adult COVID-19 COVID-19 - epidemiology Disease Outbreaks disease severity Hospitals Humans Omicron SARS-CoV-2 Severity of Illness Index South Africa South Africa - epidemiology Tshwane |
SummonAdditionalLinks | – databaseName: Elsevier SD Freedom Collection dbid: .~1 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELaqHhASQqW8wktG4gZh61ecHKFQVUjlApX2ZjmOzaZUSbWPcuPED2cmdlYbkIrELXLsTbzzeTwTzzdDyKsjZ1Whnc-DalwOK5HnVQ1XutLgYZeFqxrkO599Lk7P5ae5mu-R45ELg2GVSfdHnT5o69QyS__m7KptZ18Y7F2VZpxjiipVzJHBLjWi_O1PtsONjHQ46Jxj70SciTFe7UWL2UI5w0-CAreonc1pyOE_2aP-tkH_DKXc2ZtODsjdZFTSd_G975E93x2SW2fp2PyQ3Ikf52jkHN0nvz4MxuLKNxQe6rF-He0DTYc1NFIXKZiGNLRgHdKYNYQigXnZd_Qa_GsQCHVI4stZRfvNGjxr-522HbX0EoPL6SIVJMG29Wrxw3b-DV1hwT5qh9pED8j5ycevx6d5KseQO1ik61wVNWuUqtGo4Ro5upZVgVnuQumlB1PQc2aVakLwogwKWspGwpp33IL_rsRDst_1nX9MaMUcIEdKZWshpdO1D0fOF5w3jaqZkBlhoxyMS7nKsWTGpRmD0i4Mys6g7AzjBmSXkdfbMVcxU8eNvd-jeLc9Mcv20NAvv5kEM1N6VvvaKYCNB0WnrQswVR1U4Z0Qvs6IGMFhRiIrqF74ofbGR6vtqAnU_znu5Yg_AzoAD3ZAdP1mZcALVuB2K1Vk5FHE43ZiQgLqSy4yoidIncx8eqdrF0Oe8RJ5xqx48p_v-5Tc5sgVGQL2npH99XLjn4MFt65fDEv0NzLcRjw priority: 102 providerName: Elsevier |
Title | Decreased severity of disease during the first global omicron variant covid-19 outbreak in a large hospital in tshwane, south africa |
URI | https://www.clinicalkey.com/#!/content/1-s2.0-S120197122101256X https://dx.doi.org/10.1016/j.ijid.2021.12.357 https://www.ncbi.nlm.nih.gov/pubmed/34971823 https://www.proquest.com/docview/2615917556 https://pubmed.ncbi.nlm.nih.gov/PMC8713416 https://doaj.org/article/8e1bebc5712e4887acff8e7f56ec33eb |
Volume | 116 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELagB4SEEJRXeFSDxA0CtR3ncaSUqgWVE5X2ZtmOrU2pEtTNwo0TP5yZOIl2QWovXKKVE2_kzEzmm3i-GcZe7Tuj8sL5NKjapWiJIq0s_iqqAiPsMndVTXzn0y_58Vn2aaEWG62-KCcslgeOD-5d6bn11qmCC4_KVhgXQumLoHLvpPSW3r7o86ZgamZERhIcure0wqkjXSZmdjXnDdUIFZw-BEpyTBsuaajcv-WZ_kWefydQbniko3vs7ggl4X1cwn12w7e77NbpuFm-y-7ET3IQmUYP2O_DASKufA14U09d66ALMG7RQCQsAgJCCA1iQoi1QoBoy5ddCz8wqkYxgCPqXsor6NY9xtPmGzQtGLiglHJYjm1IaKxfLX-a1r-BFbXpAzN0JHrIzo4-fv1wnI5NGFKHptmnKre8VsoSlBEFMXMNrwI3wqEYMo8A0AtulKpD8LIMCkfKOkNLd8Jg1K7kI7bTdq1_wqDiDvUly5SxMstcYX3Ydz4Xoq6V5TJLGJ_koN1YoZwaZVzoKRXtXJPsNMlOc6FRdgl7Pc_5HutzXHn1AYl3vpJqaw8DqHF61Dh9ncYlTE7KoSf6Kr5w8Y-aK2-t5lkjuImg5dp5Lyf902j5tJ2DouvWK42xr8JgW6k8YY-jPs4LkxlqfSlkwootTd1a-faZtlkO1cVLYhfz_On_eFTP2G1BdJEhZ-852-kv1_4Fgrje7rGbb39xPB6efN4bbBePJ4uDP1RrSoU |
linkProvider | Directory of Open Access Journals |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwELaqIgESQlBeW16DBCdIt3biPA4cgFJtabcXWmlvxnFsNm2VVPug4sKJf8QfZCZxVrsgFQmpt5U3TuzM5_FMPN8MYy-3jZZxYmzgZGECXIkiyHL8lWQJethpbLKC-M7Dw3hwHH0aydEa-9VxYSis0uv-Vqc32tq39P3b7J-XZf8zx70rS7gQlKJKxiMfWblvv1-g3zZ9u7eDQn4lxO7How-DwJcWCAwCbhbIOOeFlDlt0CIhvqnmmeNaGJfayKJZYwXXUhbO2TB1ElvSIkL8GqHRF6VSEaj3r0WoLqhswtYPvkTGbPl3OLqAhueZOm1QWXlSUnpSwekbZEh74tJu2BQNWNkU_zZ6_4zdXNoMd--w296KhXfti7rL1my1wa4P_Tn9BrvVfg2EluR0j_3caazTqS0AH2qpYB7UDvzpELRcSUBbFFyJ5ii0aUqAGNOTuoJv6NAjAsAQazDgGdTzGbry-hTKCjScUTQ7jH0FFGqbTccXurJvYEoVAkE3xZDus-MrEdIDtl7VlX3EIOMGoRpFUudhFJkkt27b2FiIopA5D6Me450clPHJ0alGx5nqouBOFMlOkewUFwpl12OvF33O29Qgl179nsS7uJLSejcN9eSr8rhWqeW5zY1E2FjUrIk2DqeaOBlbE4Y277GwA4fqmLOo6_FG5aWPloteK2vrn_1edPhTqHToJAlFV8-nCt1uiX6-lHGPPWzxuJhYGCHqUxH2WLKC1JWZr_5TleMmsXlKxGYeb_7neJ-zG4Oj4YE62Dvcf8xuCiKqNNGCT9j6bDK3T9F8nOXPmuUK7MtV64ffHICCwg |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Decreased+severity+of+disease+during+the+first+global+omicron+variant+covid-19+outbreak+in+a+large+hospital+in+tshwane%2C+south+africa&rft.jtitle=International+journal+of+infectious+diseases&rft.au=Abdullah%2C+F.&rft.au=Myers%2C+J.&rft.au=Basu%2C+D.&rft.au=Tintinger%2C+G.&rft.date=2022-03-01&rft.issn=1201-9712&rft.volume=116&rft.spage=38&rft.epage=42&rft_id=info:doi/10.1016%2Fj.ijid.2021.12.357&rft.externalDBID=n%2Fa&rft.externalDocID=10_1016_j_ijid_2021_12_357 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1201-9712&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1201-9712&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1201-9712&client=summon |